Allele Mail Bag
Allele’s Online Community
Allele Biotech’s participation in social networking sites (Twitter, Facebook, and MySpace has been successful over the past few months! We initiated contact with our customers via these websites not only to provide an easy way to let people know about our newest products and promotions but, most importantly, to ensure better customer service through an easily accessible forum for questions, comments, and yes, even criticisms. We are not like those other companies that are so large that your business and opinions do not matter to us. We at Allele Biotech need and appreciate our customers and reward your patronage and participation in these social networking forums with special promotions and customer service that really lets you know we value your online community membership. Your research goals are our research goals!
Several times a week our tweets will inform you about great deals like FREE SHIPPING on select products ordered within a specific time frame.
Our regular blogs found on all three of our sites are used to converse on a variety of topics from SBIR grants to fluorescent proteins to skin care!
On facebook and myspace you can submit technical questions on protocol or products and receive SAME DAY answers; you may also send comments and suggestions for improvement which will be seen by our head scientist and executives. Your opinion counts at Allele! We began this networking concept as not only a way to better reach our customers but, more importantly, as a way for them to better reach us.
Become a friend, fan, or follower to any one of the sites today and receive a $30 discount off your next order!
Allele Mail Bag: Our discovery that stem cells and other cells can be non-invasively intranasally delivered to the brain.
A few words from the blog editor: The Allele Mail Bag is a new feature we initiated here by this post on July 20, 2009. We like to post some of the messages that our research, business development, or customer service staff receives through Allele’s published email boxes, e.g. oligo@allelebiotech.com (for ordering any product or service), iPS@allelebiotech.com, RNAi@allelebiotech.com, FP@allelebiotech.com, Vivec@allelebiotech.com (for consulting with Allele experts on each of the focus product group. FP: fluorescent proteins. Vivec: viral vectors). If we find your message to be suitable as a guest post on our blog, we will ask for your permission first.
In addition to any questions about any product, service, or R&D activity that Allele may provide or perform, we also encourage you to use our communication and social networking channels to help more people become aware of your own research progress. After all, it is by the same principle of scientific information exchange through traditional channels such as publication in journals or presentation at meetings—the better we communicate the more science benefits.
Excerpt from a recent email to iPS@allelebiotech.com, with permission from Dr. Frey:
“Hi,
I am excited to tell you that along with my collaborators in Germany, especially Lusine Danielyan MD, I have discovered that stem cells and other therapeutic cells can be non-invasively delivered to the brain using the intranasal delivery method that I developed. The first of our papers on this new discovery was just published in European Journal of Cell Biology. I have attached a copy of this paper. I am hopeful that this breakthrough, that could revolutionize the stem cell industry and make stem cell treatments practical by eliminating the need for invasive neurosurgical implantation of cells, can facilitate the development of stem cell therapies for Parkinson’s disease, Alzheimer’s disease, stroke, traumatic brain injury and many other brain disorders.
Best Regards,
—
William H. Frey II, Ph.D., Director
Alzheimer’s Research Center
Regions Hospital
640 Jackson St.
St. Paul, MN 55101
Professor of Pharmaceutics, Neurology
and Neuroscience
University of Minnesota”
Categories
- Allele Mail Bag
- cGMP
- Customer Feedback
- Fluorescent proteins
- iPSCs and other stem cells
- nAb: Camelid Antibodies, Nanobodies, VHH
- Next Generation Sequencing (NextGen Seq)
- NIH Budget and You
- oligos and cloning
- Open Forum
- RNAi patent landscape
- SBIR and Business issues
- State of Research
- Synthetic biology
- Uncategorized
- Viruses and cells
- You have the power
Archives
- October 2018
- April 2018
- March 2018
- January 2018
- October 2017
- September 2017
- August 2017
- March 2017
- February 2017
- January 2017
- November 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- February 2016
- October 2015
- September 2015
- August 2015
- June 2015
- March 2015
- January 2015
- December 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- May 2012
- April 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- October 2008
- August 2008
- July 2008